By Sriparna Roy (Reuters) -Telehealth firms Teladoc and LifeMD said on Thursday they had signed an agreement to offer Eli Lilly's weight-loss drug Zepbound to self-paying patients, ahead of restrictions on selling copies known as compounded drugs.

Doctor, doctor, give me the news, Hims & Hers Health (HIMS) has got bad case of the stock market blues. The San Francisco telehealth company could've used some strong medicine on March 6 when its shares took sick amid a court ruling and stepped up competition involving weight-loss drugs.

Dr. Marty Makary will testify before the Senate health committee on Thursday. Lawmakers may press him over staff reductions and changes in agency direction on issues like vaccines.

For nearly five years, people with attention deficit/hyperactivity disorder have had the option of getting their stimulant medications prescribed and renewed by doctors they see only over a computer screen,

Ro Khanna (D-Calif.) posted a video on TikTok informing his 400,000 followers of “breaking news” that “the Trump administration announced that Medicare will stop covering telehealth on April 1st,” and calling for opposition to “stand up to these Medicare cuts.

Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a

Pfizer CEO Albert Bourla said the drugmaker might move overseas manufacturing to its plants in the U.S. as Trump threatens import tariffs

Amidst the nation’s fentanyl crisis, the federal exemptions made special allowances for buprenorphine, specifically allowing its prescribing via audio-only encounters in addition to audio-visual ones.

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration’s ... and are what telehealth companies have utilized to sell compounded GLP-1s.

Feb 21 (Reuters) - The U.S. Food and Drug Administration said on Friday there was no longer ... it have been turning to often cheaper versions sold by pharmacies and telehealth providers like Hims & Hers and WeightWatchers WW.O. Wegovy has ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.